Won Woo Lee
Papers
1
Total Citations
7
H-Index
1
About
Won Woo Lee is a leading figure in nuclear medicine and molecular imaging, with a focused expertise on the use of positron emission tomography (PET) for oncologic diagnosis. His primary research investigates the diagnostic accuracy of novel radiopharmaceuticals, particularly F-18-Fluorocholine, in detecting prostate cancer. In a landmark 2022 study, Lee systematically compared the diagnostic efficacy of F-18-Fluorocholine PET/CT against multiparametric MRI, providing critical evidence on the strengths of each modality for lesion detection and staging. This work, which has already garnered 7 citations, has helped clarify the clinical roles of these advanced imaging techniques, guiding urologists and oncologists toward more precise, non-invasive diagnostic pathways. Lee’s contributions are instrumental in advancing the field of theranostics, where imaging and therapy are increasingly integrated. His research not only improves cancer detection rates but also reduces unnecessary biopsies, directly impacting patient management. As a researcher dedicated to refining metabolic imaging, Lee continues to shape the future of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1